FDA Warns Against Using Terbutaline to Prevent Preterm Labor

FDA Warns Against Using Terbutaline to Prevent Preterm Labor

The United States Food and Drug Administration (FDA) has determined that using Terbutaline to prevent preterm labor poses unsafe cardiovascular risks to pregnant women. They now recommend that obstetricians and maternal fetal medicine specialists stop using the medication for this purpose. For more information and to read the news release, visit the FDA Website.